Melanoma Clinical Trial

INTER-PATHOLOGIST READER STUDY

Summary

This is a post study histology analysis from previously obtained pathology slides.

View Full Description

Full Description

This is a post study histology analysis. Pathologists will use digital histology slide scans of suspicious nevus/nevi obtained from previously conducted studies to provide histopathology gradations of histological features as outlined in the Orlucent histology atlas (LBL0713 Histopathology Atlas for Grading of Dysplastic Nevi and DEF0713-1 Histopathology Definitions for LBL0713).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histology scans must have been obtained from previous consented subjects that allows post study ad hoc analyses.
Histology scans must be available from the data collected from the Orlucent OMS002, SFI001 or SFI003 Studies and are of good quality.

Exclusion Criteria:

NA

Study is for people with:

Melanoma

Estimated Enrollment:

500

Study ID:

NCT06246903

Recruitment Status:

Enrolling by invitation

Sponsor:

Orlucent, Inc

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Utah Hospital, Pathology
Salt Lake City Utah, 84132, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

500

Study ID:

NCT06246903

Recruitment Status:

Enrolling by invitation

Sponsor:


Orlucent, Inc

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.